Crossmark

Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model

Crossref DOI link: https://doi.org/10.1136/jitc-2020-001524

Published Online: 2021-02-16

Published Print: 2021-02

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Wen, Jing

Wang, Lan

Ren, Jie

Kranz, Emiko

Chen, Shilin

Wu, Di

Kanazawa, Toshio

Chen, Irvin

Lu, Yunfeng

Kamata, Masakazu https://orcid.org/0000-0003-0323-3742
Funding

Funding for this research was provided by:

National Cancer Institute (CA232015)

National Cancer Institute (CA253215)

National Institute of Allergy and Infectious Diseases (AI110200)
License Information

License valid from 2021-02-16